Miami Valves
Avatar

Suprasternal Direct Aortic Approach TAVR Avoid Sternotomy and Thracotomy: First In Man Experience

By Miami Valves FEATURING Andy Kiser
January 13, 2015
5 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Teleflex
Optimizing Efficiency in TAVR: Large Bore Access Site Management
Thu, Nov 12, 2020
Faculty: Bruce Rutkin , Teleflex .
Boston Scientific
Lifetime Management and Cerebral Embolic Protection in TAVR
Thu, Apr 14, 2022
Faculty: Boston Scientific , Kendra Grubb , Thomas Waggoner
Boston Scientific
Practical Use of SENTINEL™ Cerebral Protection System & Insights fro…
Wed, Dec 14, 2022
Faculty: Boston Scientific , Michael Rinaldi , Vinod Thourani
24:31
Vinod Thourani

How Do I Treat Low Gradient & Severe Aortic Stenosis?

15:28
Scripps Health

TAVR for Aortic Insufficiency - Current Options

Feat. C. Stinis
18:42
McMaster University Department of Medicine

Geriatric Perspectives in TAVR Assessment and Outcomes

Feat. M. Au
16:05
Shockwave IVL

IVL in Practice, Patient Selection and Cases: IVL Pre TAVI Tutorial …

Feat. O. De Backer
05:43
Shockwave IVL

Why Take the Transfemoral Route? IVL Pre TAVI Tutorial Chapter 1

Feat. O. De Backer
36:11
ARCH Advanced Revascularization Symposium

The UPSTREAM Management of Aortic Stenosis in the Future

Feat. M. Leon
70:52
Medtronic

Post-TAVR Coronary Access: Hands-on with the Heartroid

Feat. D. Talreja
09:48
American College of Cardiology

PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…

Feat. D. Adams, V. Fuster, R. Mehran, A. Lala-Trindade, V. Reddy
12:45
Scripps Health: 2019 Eighth Annual Structural Heart Intervention and Imaging

Cerebral Protection for TAVR: When and Why

Feat. D. Rizik
17:08
JenaValve

TVT 2021 - The Future Role of TAVR in Aortic Regurgitation Therapy: …

Feat. T. Vahl, O. Ben-Yehuda, M. Mack
13:53
JenaValve

TVT 2021 - Characterizing the Transcatheter Need for High-Risk Sever…

Feat. T. Vahl, V. Thourani, M. Mack, H. Treede
29:50
University of Miami

Catheter Based Treatment of Structural Heart Disease - Year in Review

Feat. E. De Marchena
91:27
JenaValve

TVT 2021 – High-Risk Severe AR with TAVR

Feat. M. Mack, T. Vahl, V. Thourani, O. Ben-Yehuda, D. Daniels, L. Ranard, N. Hamid, T. Cahill, H. Treede, D. Kereiakes
56:22
JenaValve

Aortic Regurgitation Webinar: A Disease State Review, Current Treatm…

Feat. V. Thourani, J. McCabe, M. Russo
11:39
JenaValve

Aortic Regurgitation Webinar - The ALIGN-AR Trial: Novel TAVR Device…

Feat. J. Mccabe
08:27
Scottsdale Interventional Forum 2023

TAVR Durability Is Sufficient: Most 60-Year-Old Patients Should Get …

Feat. J. Lasala
08:44
Shockwave IVL

How to Use IVL to Facilitate TF Access: IVL Pre TAVI Tutorial Chapte…

Feat. O. De Backer
07:51
Shockwave IVL

The Copenhagen Experience: IVL Pre TAVI Tutorial Chapter 3

Feat. O. De Backer
16:01
JenaValve

Aortic Regurgitation Webinar - Q&A on TAVR for Aortic Regurgitat…

Feat. V. Thourani, M. Russo, J. McCabe
05:17
Boston Scientific

Cerebral Embolic Protection with SENTINEL: Technology Overview and …

Feat. H. Gada